PAS
XBIT icon

Point72 Asia (Singapore)’s XBiotech XBIT Stock Holding History

Point72 Asia (Singapore)’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$18.1K Sell
6,817
-6,908
-50% -$20.5K ﹤0.01% 724
2025
Q2 		$40.8K Buy
+13,725
New +$39.9K 0.01% 633
2024
Q2 		– Sell
-25,954
Closed -$211K – 1549
2024
Q1 		$211K Buy
+25,954
New +$149K 0.05% 413

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Point72 Asia (Singapore)'s XBIT Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its XBiotech (XBIT) stake by 50% in Q3 2025, selling an estimated $20.5K and leaving 6,817 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Point72 Asia (Singapore) first reported a position in XBIT in Q1 2024 and has held it in 3 quarters since. The position peaked at $211K in Q1 2024. 48 funds tracked by Wall St. Rank hold XBIT as of Q3 2025.

  • Point72 Asia (Singapore) held 6,817 shares of XBiotech worth $18.1K as of Q3 2025.
  • Point72 Asia (Singapore) sold 6,908 XBiotech shares in Q3 2025, an estimated $20.5K.
  • XBiotech made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #724 holding.
  • Point72 Asia (Singapore) first reported a position in XBiotech in Q1 2024 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s XBiotech position peaked at $211K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held XBiotech as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.